Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Hypogonadism and cancer survivorship
Cory A. Faw,
Robert E. Brannigan
*
*
Corresponding author for this work
Urology
Research output
:
Contribution to journal
›
Article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Hypogonadism and cancer survivorship'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Survivorship
100%
Hypogonadism
100%
Sexual Behavior
66%
Cancer Treatment
33%
Quality of Life
33%
Infertility
33%
Testosterone
33%
Treatment Regimen
33%
Therapeutic Benefits
33%
Randomized Controlled Trial
33%
Cancer Therapy
33%
Body Composition
33%
Oncologic
33%
Survivorship Issues
33%
Patients with Cancer
33%
Cancer Survivors
33%
Oncological Treatment
33%
High Prevalence
33%
Muscle Mass
33%
Risk Outcomes
33%
Risk-benefit
33%
Bone Health
33%
Overall Outcome
33%
Bone Mineral Density
33%
Testosterone Deficiency
33%
Hypothalamic-pituitary-gonadal Axis
33%
Prior Treatment
33%
Fat Mass
33%
Testosterone Replacement Therapy
33%
Libido
33%
Sense of Well-being
33%
Medicine and Dentistry
Malignant Neoplasm
100%
Survivorship in Cancer Care
100%
Hypogonadism
100%
Prevalence
25%
Prospective Study
25%
Physical Disease by Body Function
25%
Bone Density
25%
Cancer Therapy
25%
Substitution Therapy
25%
Androgen Therapy
25%
Libido
25%
Androgen Deficiency
25%
Quality of Life
25%
Clinician
25%
Randomized Controlled Trial
25%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Hypogonadism
100%
Prospective Study
14%
Replacement Therapy
14%
Randomized Controlled Trial
14%
Prevalence
14%
Physical Disease by Body Function
14%
Androgen Deficiency
14%